Sandbox Reserved 895: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Ivan E. Wang (talk | contribs) No edit summary |
Ivan E. Wang (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
</StructureSection> | </StructureSection> | ||
[[http://proteopedia.org/wiki/images/4/4b/RPE65_with_emixustat.mp4|thumb|right|512 px|]] | |||
= Structure and Activity = | = Structure and Activity = | ||
| Line 33: | Line 36: | ||
Historically (''R'')-Emixustat was tested as a possible treatment for dry (atrophic) age-related macular degeneration in Phase IIb/III clinical trials but failed to show clinical outcomes due to significant pharmacokinetic and pharmacodynamic short falls. | Historically (''R'')-Emixustat was tested as a possible treatment for dry (atrophic) age-related macular degeneration in Phase IIb/III clinical trials but failed to show clinical outcomes due to significant pharmacokinetic and pharmacodynamic short falls. | ||
</StructureSection> | </StructureSection> | ||
